194 related articles for article (PubMed ID: 10534724)
1. Artificial NS4 mosaic antigen of hepatitis C virus.
Chang JC; Ruedinger B; Cong M; Lambert S; Lopareva E; Purdy M; Holloway BP; Jue DL; Ofenloch B; Fields HA; Khudyakov YE
J Med Virol; 1999 Dec; 59(4):437-50. PubMed ID: 10534724
[TBL] [Abstract][Full Text] [Related]
2. Antigenic heterogeneity of the hepatitis C virus NS4 protein as modeled with synthetic peptides.
Chang JC; Seidel C; Ofenloch B; Jue DL; Fields HA; Khudyakov YE
Virology; 1999 Apr; 257(1):177-90. PubMed ID: 10208931
[TBL] [Abstract][Full Text] [Related]
3. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C epitopes from phage-displayed cDNA libraries and improved diagnosis with a chimeric antigen.
Pereboeva LA; Pereboev AV; Wang LF; Morris GE
J Med Virol; 2000 Feb; 60(2):144-51. PubMed ID: 10596013
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a linear epitope in the nonstructural region 4 of hepatitis C virus with reactivity to seroconversion antibodies.
Wienhues U; Ihlenfeldt HG; Seidel C; Schmitt U; Kraas W; Jung G
Virology; 1998 Jun; 245(2):281-8. PubMed ID: 9636367
[TBL] [Abstract][Full Text] [Related]
6. A new artificial antigen of the hepatitis E virus.
Ulanova TI; Obriadina AP; Talekar G; Burkov AN; Fields HA; Khudyakov YE
J Immunoassay Immunochem; 2009; 30(1):18-39. PubMed ID: 19117200
[TBL] [Abstract][Full Text] [Related]
7. Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies.
Muerhoff AS; Gutierrez R; Kyrk C; Leary T; Schlauder G; Dawson G; Desai SM
J Med Virol; 2008 Mar; 80(3):411-8. PubMed ID: 18205228
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to a novel antigen in acute hepatitis C virus infections.
Tobler LH; Stramer SL; Chien DY; Lin S; Arcangel P; Phelps BH; Cooper SL; Busch MP
Vox Sang; 2007 Jan; 92(1):1-7. PubMed ID: 17181584
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of a panel of monoclonal antibodies raised against recombinant HCV core protein.
Ferns RB; Tuke PW; Sweenie CH
J Med Virol; 1996 Nov; 50(3):221-9. PubMed ID: 8923286
[TBL] [Abstract][Full Text] [Related]
11. Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase.
Jolivet-Reynaud C; Adida A; Michel S; Deléage G; Paranhos-Baccala G; Gonin V; Battail-Poirot N; Lacoux X; Rolland D
J Med Virol; 2004 Mar; 72(3):385-95. PubMed ID: 14748062
[TBL] [Abstract][Full Text] [Related]
12. A novel antigen detection immunoassay for field diagnosis of hepatitis C virus infection.
Attallah AM; Ismail H; Tabll AA; Shiha GE; El-Dosoky I
J Immunoassay Immunochem; 2003; 24(4):395-407. PubMed ID: 14677657
[TBL] [Abstract][Full Text] [Related]
13. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kuzuya T; Honda T; Hayashi K; Nakano I; Katano Y; Goto H
Clin Infect Dis; 2005 Mar; 40(6):e49-54. PubMed ID: 15736006
[TBL] [Abstract][Full Text] [Related]
14. A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein.
Cerino A; Boender P; La Monica N; Rosa C; Habets W; Mondelli MU
J Immunol; 1993 Dec; 151(12):7005-15. PubMed ID: 7505020
[TBL] [Abstract][Full Text] [Related]
15. [Gene chimeric fusion and expression of nucleocapsid NS3 regions and NS4 regions of hepatitis C virus genome].
Shen XC; Li M; Wu XF
Sheng Wu Gong Cheng Xue Bao; 2001 Jan; 17(1):46-9. PubMed ID: 11330186
[TBL] [Abstract][Full Text] [Related]
16. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.
Chu CM; Sheen IS; Liaw YF
Scand J Gastroenterol; 2004 Aug; 39(8):778-82. PubMed ID: 15513365
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
[TBL] [Abstract][Full Text] [Related]
18. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
[TBL] [Abstract][Full Text] [Related]
19. Sequence analysis of hepatitis C virus variants producing discrepant results with two different genotyping assays.
Prescott LE; Berger A; Pawlotsky JM; Conjeevaram P; Pike I; Simmonds P
J Med Virol; 1997 Nov; 53(3):237-44. PubMed ID: 9365889
[TBL] [Abstract][Full Text] [Related]
20. Genotype 1 and global hepatitis C T-cell vaccines designed to optimize coverage of genetic diversity.
Yusim K; Fischer W; Yoon H; Thurmond J; Fenimore PW; Lauer G; Korber B; Kuiken C
J Gen Virol; 2010 May; 91(Pt 5):1194-206. PubMed ID: 20053820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]